Literature DB >> 20439735

SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling.

Kimberly R Holloway1, Tara N Calhoun, Madhurima Saxena, Cheynita F Metoyer, Ethan F Kandler, Chantal A Rivera, Kevin Pruitt.   

Abstract

Sirtuin 1 (SIRT1) is a class III histone deacetylase that deacetylates histone and nonhistone proteins to regulate gene transcription and protein function. Because SIRT1 regulates very diverse responses such as apoptosis, insulin sensitivity, autophagy, differentiation, and stem cell pluripotency, it has been a challenge to reconcile how it orchestrates such pleiotropic effects. Here we show that SIRT1 serves as an important regulator of Wnt signaling. We demonstrate that SIRT1 loss of function leads to a significant decrease in the levels of all three Dishevelled (Dvl) proteins. Furthermore, we demonstrate that SIRT1 and Dvl proteins complex in vivo and that inhibition of SIRT1 leads to changes in gene expression of Wnt target genes. Finally, we demonstrate that Wnt-stimulated cell migration is inhibited by a SIRT1 inhibitor. Because the three mammalian Dvl proteins serve as key messengers for as many as 19 Wnt ligands, SIRT1-mediated regulation of Dvl proteins may explain the diverse physiological responses observed in different cellular contexts. Previously, SIRT1 had only been shown to mediate the epigenetic silencing of Wnt antagonists. In contrast, here we report that SIRT1 regulates Dvl protein levels and Wnt signaling in several cellular contexts. These findings demonstrate that SIRT1 is a regulator of transient and constitutive Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439735      PMCID: PMC2889068          DOI: 10.1073/pnas.0911325107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.

Authors:  Haiyun Deng; Ryouji Makizumi; T S Ravikumar; Huali Dong; Wancai Yang; Weng-Lang Yang
Journal:  Exp Cell Res       Date:  2007-01-10       Impact factor: 3.905

2.  Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3'-end processing.

Authors:  Tadahiro Shimazu; Sueharu Horinouchi; Minoru Yoshida
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

3.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

Review 4.  Mining the Wnt pathway for cancer therapeutics.

Authors:  Nick Barker; Hans Clevers
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.

Authors:  J C Tapia; V A Torres; D A Rodriguez; L Leyton; A F G Quest
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

6.  Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha.

Authors:  Li Qiang; Hong Wang; Stephen R Farmer
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

7.  Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells.

Authors:  Susmita Esufali; George S Charames; Vaijayanti V Pethe; Pinella Buongiorno; Bharati Bapat
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

8.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

9.  Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.

Authors:  Kevin Pruitt; Rebekah L Zinn; Joyce E Ohm; Kelly M McGarvey; Sung-Hae L Kang; D Neil Watkins; James G Herman; Stephen B Baylin
Journal:  PLoS Genet       Date:  2006-03-31       Impact factor: 5.917

10.  Myc deletion rescues Apc deficiency in the small intestine.

Authors:  Owen J Sansom; Valerie S Meniel; Vanesa Muncan; Toby J Phesse; Julie A Wilkins; Karen R Reed; J Keith Vass; Dimitris Athineos; Hans Clevers; Alan R Clarke
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

View more
  51 in total

1.  ATG4B promotes colorectal cancer growth independent of autophagic flux.

Authors:  Pei-Feng Liu; Chung-Man Leung; Yu-Hsiang Chang; Jin-Shiung Cheng; Jih-Jung Chen; Chung-Jeu Weng; Kuo-Wang Tsai; Chien-Jen Hsu; Yen-Chen Liu; Ping-Chi Hsu; Hung-Wei Pan; Chih-Wen Shu
Journal:  Autophagy       Date:  2014-06-12       Impact factor: 16.016

Review 2.  Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.

Authors:  Meghan O Blaya; Joseph M Wasserman; Andrew A Pieper; Thomas J Sick; Helen M Bramlett; W Dalton Dietrich
Journal:  Neuropharmacology       Date:  2018-09-17       Impact factor: 5.250

3.  The Roles of SIRT1 in Cancer.

Authors:  Zhenghong Lin; Deyu Fang
Journal:  Genes Cancer       Date:  2013-03

4.  SIRT1 inhibits the mouse intestinal motility and epithelial proliferation.

Authors:  Yi Wang; Xuemei Shi; Jian Qi; Xiaojie Li; Karen Uray; Xinfu Guan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

Review 5.  Inflammatory pathways in the early steps of colorectal cancer development.

Authors:  Francesco Mariani; Paola Sena; Luca Roncucci
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Dishevelled: A masterful conductor of complex Wnt signals.

Authors:  Monica Sharma; Isabel Castro-Piedras; Glenn E Simmons; Kevin Pruitt
Journal:  Cell Signal       Date:  2018-03-17       Impact factor: 4.315

Review 7.  Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.

Authors:  Shafat Ali; Shazia Nafis; Ponnusamy Kalaiarasan; Ekta Rai; Swarkar Sharma; Rameshwar N Bamezai
Journal:  Rev Diabet Stud       Date:  2016-05-10

Review 8.  Sirtuin inhibitors as anticancer agents.

Authors:  Jing Hu; Hui Jing; Hening Lin
Journal:  Future Med Chem       Date:  2014-05       Impact factor: 3.808

9.  SIRT1 positively regulates breast cancer associated human aromatase (CYP19A1) expression.

Authors:  Kimberly R Holloway; Andreia Barbieri; Svitlana Malyarchuk; Madhurima Saxena; Ana Nedeljkovic-Kurepa; Mathieu Cameron Mehl; Allison Wang; Xin Gu; Kevin Pruitt
Journal:  Mol Endocrinol       Date:  2013-01-22

Review 10.  Sorting out functions of sirtuins in cancer.

Authors:  M Roth; W Y Chen
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.